SAB Biotherapeutics SABS
NASDAQ SABS
$3.06 -0.11 (-3.47%)
At close: Oct 1, 2026 · 4:00 PM EDT

SAB Biotherapeutics (SABS) Other Operating Expenses (2020)

Updated

SAB Biotherapeutics' Other Operating Expenses came in at $8,996 for Q4 2020.

Analysis

SAB Biotherapeutics (SABS) Other Operating Expenses (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 SAB Biotherapeutics 264.67 Mn 264.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 8,996.00
API Access

SAB Biotherapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=SABS&period=max&api_key=YOUR_API_KEY